ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,617Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 96

$587K Total Retail Price of All Prescriptions

Rank: 26 out of 96

408 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 9,690 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 518 485 1 1
AMLODIPINE BESYLATE 462 433 2 2
LEVOTHYROXINE SODIUM 409 387 3 3
FUROSEMIDE 366 353 4 4
METOPROLOL TARTRATE 323 317 5 7
DONEPEZIL HCL 253 253 6 8
OMEPRAZOLE 247 205 7 5
METFORMIN HCL 224 193 8 13
ATORVASTATIN CALCIUM 207 186 9 12
WARFARIN SODIUM 197 186 10 6
RISPERIDONE 173 173 11 31
MIRTAZAPINE 166 159 12 14
LOSARTAN POTASSIUM 157 157 13 23
METOPROLOL SUCCINATE 153 126 14 9
CARVEDILOL 152 139 15 22
LISINOPRIL 150 141 16 10
NAMENDA 143 143 17 11
DIOVAN 128 120 18 17
HYDROCHLOROTHIAZIDE 124 84 19 16
NYSTATIN 123 121 20 86
POTASSIUM CHLORIDE 110 98 21 19
CLOPIDOGREL 109 101 22 27
ENALAPRIL MALEATE 104 90 23 28
GLIPIZIDE 103 81 24 62
SERTRALINE HCL 101 94 25 15
CARBIDOPA-LEVODOPA 97 97 26 48
ALENDRONATE SODIUM 94 91 27 36
ESCITALOPRAM OXALATE 89 76 28 24
TAMSULOSIN HCL 87 87 29 29
LOSARTAN-HYDROCHLOROTHIAZIDE 82 69 30 88
PLAVIX 82 77 30 42
GENERLAC 81 81 32 129
GABAPENTIN 81 74 32 20
JANUVIA 81 81 32 49
ENULOSE 80 80 35 162
TRAMADOL HCL 79 77 36 35
NEXIUM 78 77 37 40
DIOVAN HCT 76 64 38 64
DIGOXIN 74 74 39 34
FAMOTIDINE 74 71 39 21
QUETIAPINE FUMARATE 72 72 41 32
LEVETIRACETAM 72 58 41 61
DIVALPROEX SODIUM 67 67 43 41
TRAZODONE HCL 67 67 43 38
LANTUS 64 63 45 68
LACTULOSE 63 39 46 37
NOVOLOG 62 62 47 142
ATENOLOL 60 60 48 30
RANITIDINE HCL 58 44 49 75
DILTIAZEM 24HR CD 55 42 50 83
LAMOTRIGINE 53 29 51 115
BYSTOLIC 53 49 51 56
NITROGLYCERIN PATCH 52 52 53 89
HYDRALAZINE HCL 51 51 54 79
PAROXETINE HCL 51 51 54 66
OXYCODONE-ACETAMINOPHEN 50 48 S2 56 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.